Amino acid supplementation in l-dopa treated Parkinson's disease patients
Authors:
- 1 December 2015
- journal article
- research article
- Published by Elsevier in Clinical Nutrition
- Vol. 34 (6) , 1189-1194
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Role of Oxidative Stress in Parkinson's DiseaseExperimental Neurobiology, 2013
- Insulinotropic and Muscle Protein Synthetic Effects of Branched-Chain Amino Acids: Potential Therapy for Type 2 Diabetes and SarcopeniaNutrients, 2012
- Dysregulation of Glutathione Homeostasis in Neurodegenerative DiseasesNutrients, 2012
- Contributions of central and systemic inflammation to the pathophysiology of Parkinson's diseaseNeuropharmacology, 2012
- Parkinson's disease, insulin resistance and novel agents of neuroprotectionBrain, 2012
- Impaired Mitochondrial Substrate Oxidation in Muscle of Insulin-Resistant Offspring of Type 2 Diabetic PatientsDiabetes, 2007
- Increase of total homocysteine concentration in cerebrospinal fluid in patients with Alzheimer's disease and Parkinson's diseaseLife Sciences, 2005
- New insights into amino acid metabolism, β-cell function and diabetesClinical Science, 2005
- Blood glutathione synthesis rates in healthy adults receiving a sulfur amino acid-free dietProceedings of the National Academy of Sciences, 2000
- Glucose, insulin, and free fatty acid metabolism in Parkinson's disease treated with levodopaClinical Pharmacology & Therapeutics, 1971